Cargando…

Switching Between Second-Generation Antipsychotics in Patients with Schizophrenia and Schizoaffective Disorder: 10-Year Cohort Study in Brazil

Objective: Switching between second-generation antipsychotics (SGAs) is a common clinical practice in the treatment of schizophrenia and schizoaffective disorders due to differences in the drugs’ tolerability and safety profiles as well as the challenge of obtaining an ideal response. However, the f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fulone, Izabela, Silva, Marcus Tolentino, Lopes, Luciane Cruz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201606/ https://www.ncbi.nlm.nih.gov/pubmed/34135752 http://dx.doi.org/10.3389/fphar.2021.638001

Ejemplares similares

Gender differences in the use of atypical antipsychotics in early-onset schizophrenia: a nationwide population-based study in Brazil
por: Fulone, Izabela, et al.
Publicado: (2021)

Use of atypical antipsychotics in the treatment of schizophrenia in the Brazilian National Health System: a cohort study, 2008-2017
por: Fulone, Izabela, et al.
Publicado: (2023)

Long-term benzodiazepine use in patients taking antidepressants in a public health setting in Brazil: a cross-sectional study
por: Fulone, Izabela, et al.
Publicado: (2018)

Risks of Adverse Neonatal Outcomes in Early Adolescent Pregnancy Using Group Prenatal Care as a Strategy for Public Health Policies: A Retrospective Cohort Study in Brazil
por: Honorato, Danylo José Palma, et al.
Publicado: (2021)

Comparative study of treatment continuation using second-generation antipsychotics in patients with schizophrenia or schizoaffective disorder
por: Azekawa, Takaharu, et al.
Publicado: (2011)

Use of second-generation antipsychotics in autism spectrum disorder: a systematic review and meta-analysis protocol
por: Lopes, Luis Phillipe Nagem, et al.
Publicado: (2023)

Sales trends of psychotropic drugs in the COVID-19 pandemic: A national database study in Brazil
por: Del Fiol, Fernando de Sá, et al.
Publicado: (2023)

Consumption Trends of Antibiotics in Brazil During the COVID-19 Pandemic
por: Del Fiol, Fernando de Sá, et al.
Publicado: (2022)

Adverse Events in Patients With Rheumatoid Arthritis and Psoriatic Arthritis Receiving Long-Term Biological Agents in a Real-Life Setting
por: de Camargo, Mayara Costa, et al.
Publicado: (2019)

Knowledge Translation for Improving the Care of Deinstitutionalized People With Severe Mental Illness in Health Policy
por: Fulone, Izabela, et al.
Publicado: (2020)

Effect of Switching to Brexpiprazole on Plasma Homovanillic Acid Levels and Antipsychotic-Related Side Effects in Patients with Schizophrenia or Schizoaffective Disorder
por: Ichinose, Mizue, et al.
Publicado: (2021)

Potentially inappropriate prescriptions for elderly people taking antidepressant: comparative tools
por: Fulone, Izabela, et al.
Publicado: (2017)

Data Sources for Drug Utilization Research in Brazil—DUR-BRA Study
por: Leal, Lisiane Freitas, et al.
Publicado: (2022)

Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study
por: Citrome, Leslie, et al.
Publicado: (2013)

Improving Care for Deinstitutionalized People With Mental Disorders: Experiences of the Use of Knowledge Translation Tools
por: Fulone, Izabela, et al.
Publicado: (2021)

Editorial: New Horizons in Health-Promoting Technologies: From Development to Rational Use
por: Lopes, Luciane Cruz, et al.
Publicado: (2020)

The Effectiveness of Cross-Tapering Switching to Ziprasidone in Patients with Schizophrenia or Schizoaffective Disorder
por: Ko, Young-Hoon, et al.
Publicado: (2014)

Factors associated with thrombocytopenia in patients with dengue fever: a retrospective cohort study
por: Castilho, Bruna M, et al.
Publicado: (2020)

Strategies to Approach Medicines Litigation: An Action Research Study in Brazil
por: Machado, Fernanda Lacerda da Silva, et al.
Publicado: (2021)

Second-Generation Long-Acting Injectable Antipsychotics and the Risk of Treatment Failure in a Population-Based Cohort
por: Janzen, Donica, et al.
Publicado: (2022)

Efficacy and Tolerability of Second-Generation Antipsychotics in Children and Adolescents With Schizophrenia
por: Kumra, Sanjiv, et al.
Publicado: (2008)

Adherence and Continuation of Treatment with First- and Second-generation Antipsychotics in Schizophrenia
por: Warikoo, Nisha, et al.
Publicado: (2014)

Updating the Comparative Evidence on Second‐Generation Antipsychotic Use With Schizophrenia
por: McDonagh, Marian S., et al.
Publicado: (2020)

PM395. The Effectiveness of Cross-Tapering Switching to Ziprasidone in Patients with Schizophrenia or Schizoaffective Disorder
por: Na, Kyoungsae, et al.
Publicado: (2016)

Use of IMMPACT domains in clinical trials of acupuncture for chronic pain: A methodological survey
por: Mazzei, Lauren Giustti, et al.
Publicado: (2020)

Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial
por: Huhn, Maximilian, et al.
Publicado: (2020)

The regulatory effects of second-generation antipsychotics on lipid metabolism: Potential mechanisms mediated by the gut microbiota and therapeutic implications
por: Chen, Hui, et al.
Publicado: (2023)

Adherence, Persistence, Readmissions, and Costs in Medicaid Members with Schizophrenia or Schizoaffective Disorder Initiating Paliperidone Palmitate Versus Switching Oral Antipsychotics: A Real-World Retrospective Investigation
por: Dickson, Matthew C., et al.
Publicado: (2022)

Pharmacogenetics and Schizophrenia—Can Genomics Improve the Treatment with Second-Generation Antipsychotics?
por: Płaza, Olga, et al.
Publicado: (2022)

Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder – expert consensus survey part 2
por: Sajatovic, Martha, et al.
Publicado: (2018)

Impact on length of stay and readmission rates when converting oral to long-acting injectable antipsychotics in schizophrenia or schizoaffective disorder
por: Chou, Fabienne, et al.
Publicado: (2016)

Severe Potential Drug-Drug Interactions and the Increased Length of Stay of Children in Intensive Care Unit
por: Lima, Elisangela da Costa, et al.
Publicado: (2020)

Relapse Prevention in Schizophrenia: A Systematic Review and Meta-Analysis of Second-Generation Antipsychotics versus First-Generation Antipsychotics
por: Kishimoto, Taishiro, et al.
Publicado: (2011)

Neurophysiological Distinction between Schizophrenia and Schizoaffective Disorder
por: Mathalon, Daniel H., et al.
Publicado: (2010)

Alcohol Use Disorder and Schizophrenia or Schizoaffective Disorder
por: Archibald, Luke, et al.
Publicado: (2019)

Cost-Effectiveness Analysis of Influenza A (H1N1) Chemoprophylaxis in Brazil
por: Vecoso, Luisa von Zuben, et al.
Publicado: (2019)

The relationship between job satisfaction, burnout syndrome and depressive symptoms: An analysis of professionals in a teaching hospital in Brazil
por: de Oliveira, Alan Maicon, et al.
Publicado: (2018)

Developments in antipsychotic therapy with regard to hypotheses for schizophrenia
por: Ackenheil, Manfred, et al.
Publicado: (2002)

Strategies Implemented by Public Institutions to Approach the Judicialization of Health Care in Brazil: A Systematic Scoping Review
por: Yamauti, Sueli Miyuki, et al.
Publicado: (2020)

Kawasaki Disease and the Use of the Rotavirus Vaccine in Children: A Systematic Review and Meta-Analysis
por: Mellone, Natália Gibim, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_euoptkgr8jms0fs481r17060fp